Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)

Leukotrap - CP2D by

Drug Labeling and Warnings

Leukotrap - CP2D by is a Prescription medication manufactured, distributed, or labeled by Haemonetics Corporation, Haemonetics Manufacturing Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

LEUKOTRAP - CP2D- anticoagulant citrate phosphate double dextrose solution 
Haemonetics Manufacturing Inc

----------

Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)

How Supplied: 250 mL CP2D Anticoagulant Solution is supplied in flexible PVC containers with a sterile, non-pyrogenic fluid path. 250 mL and 300 mL AS-3 Nutrient Solution is supplied in flexible PVC containers with a sterile, non-pyrogenic fluid path.

PRINCIPAL DISPLAY PANEL

LEUKOTRAP - CP2D 
anticoagulant citrate phosphate double dextrose solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 53157-455
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE, UNSPECIFIED FORM4.64 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM CITRATE (UNII: 1Q73Q2JULR) 2.63 g  in 100 mL
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) 0.327 g  in 100 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) 0.222 g  in 100 mL
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 53157-455-02250 mL in 1 BAG; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDABN82091510/09/201910/31/2024
Labeler - Haemonetics Manufacturing Inc (078598396)
Registrant - Haemonetics Corp (057827420)
Establishment
NameAddressID/FEIBusiness Operations
Haemonetics Manufacturing Inc078598396manufacture(53157-455)

Revised: 1/2025